Sentien Biotechnologies (Series A)
Funding Details
Awarder
Inbox
Date Award
August 10, 2015
Vertical
Regenerative Medicine
Funding URL
View Funding Page
Company Info
Founders
Brian Miller
Market
Critical Care
Location
Medford, MA, USA
Coinvestors
Boehringer Ingelheim Venture Fund, Portage Biotech
Company Description

Sentien is a developer of new blood conditioning therapies designed to restore balance to the immune system of critically ill patients.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Regenerative Medicine DealsView Funding Announcement